Skip to main content
Top
Published in: Rheumatology International 6/2012

01-06-2012 | Original Article

Lipoic acid prevents steroid-induced osteonecrosis in rabbits

Authors: Bang-Bao Lu, Kang-Hua Li

Published in: Rheumatology International | Issue 6/2012

Login to get access

Abstract

The objective of this study was to investigate in vivo effects of lipoic acid (LA) in preventing steroid-induced osteonecrosis and the possible pathway in a rabbit model. Sixty rabbits were divided into 2 groups: rabbits were intraperitoneally injected with LA aqueous solution at 36 mg/kg of body weight per day for 4 weeks in Group A and rabbits were injected with physiologic saline (PS) as a control in Group B. At 2 weeks after starting treatment, they were intramuscularly injected once with 20 mg/kg of methylprednisolone acetate (MPSL). The femora were histopathologically examined for the presence of osteonecrosis. The plasma levels of total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), glutathione (GSH), endothelin (ET) and malondialdehyde (MDA) were assayed at 2 weeks after the injection of MPSL. The incidence of osteonecrosis was significantly higher in Group B (73.1%) than in Group A (20.8%). The GSH level was higher in Group A than in Group B after the LA injection. The plasma MDA and ET levels were lower in Group A than in Group B at 2 weeks after the MPSL administration. Lipoic acid can prevent the development of steroid-induced osteonecrosis in rabbits. Inhibited oxidative stress and amendment of vascular endothelial dysfunction is a possible mechanism for this effect.
Literature
1.
go back to reference Mont MA, Hungerford DS (1995) Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77:459–474PubMed Mont MA, Hungerford DS (1995) Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77:459–474PubMed
2.
go back to reference Wang GJ, Cui Q, Balian G (2000) The pathogenesis and prevention of steroid induced osteonecrosis. Clin Orthop 370:295–310PubMedCrossRef Wang GJ, Cui Q, Balian G (2000) The pathogenesis and prevention of steroid induced osteonecrosis. Clin Orthop 370:295–310PubMedCrossRef
3.
go back to reference Miyanishi K, Yamamoto T, Irisa T et al (2002) Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 30:185–190PubMedCrossRef Miyanishi K, Yamamoto T, Irisa T et al (2002) Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 30:185–190PubMedCrossRef
4.
go back to reference Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology 44:456–460PubMedCrossRef Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology 44:456–460PubMedCrossRef
5.
go back to reference Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412PubMedCrossRef Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412PubMedCrossRef
6.
7.
go back to reference Yamamoto T, Irisa T, Sugioka Y, Sueishi K (1997) Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid induced osteonecrosis in rabbits. Arthritis Rheum 40:2055–2064PubMedCrossRef Yamamoto T, Irisa T, Sugioka Y, Sueishi K (1997) Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid induced osteonecrosis in rabbits. Arthritis Rheum 40:2055–2064PubMedCrossRef
8.
go back to reference Matsui M, Saito S, Ohzono K (1992) Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis. Clin Orthop 277:61–72PubMed Matsui M, Saito S, Ohzono K (1992) Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis. Clin Orthop 277:61–72PubMed
9.
go back to reference Vatassery GT, Krezowski AM, Eckfeldt JH (1983) Vitamin E concentrations in human blood plasma and platelets. Am J Clin Nutr 37:1020–1024PubMed Vatassery GT, Krezowski AM, Eckfeldt JH (1983) Vitamin E concentrations in human blood plasma and platelets. Am J Clin Nutr 37:1020–1024PubMed
10.
go back to reference Jones J Jr (1993) Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop 292:294–308PubMed Jones J Jr (1993) Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop 292:294–308PubMed
11.
go back to reference Lee K, Park SY, Lee DH et al (2002) Lovastatin increases longitudinal bone growth and bone morphogenetic protein-2 levels in the growth plate of Sprague Dawley rats. Eur J Pediatr 161:406–407PubMedCrossRef Lee K, Park SY, Lee DH et al (2002) Lovastatin increases longitudinal bone growth and bone morphogenetic protein-2 levels in the growth plate of Sprague Dawley rats. Eur J Pediatr 161:406–407PubMedCrossRef
12.
go back to reference Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y (2004) Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 50:3387–3391PubMedCrossRef Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y (2004) Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 50:3387–3391PubMedCrossRef
13.
go back to reference Zhang G, Qin L, Sheng H, Wang XL, Wang YX, Yeung DK, Griffith JF, Yao XS, Xie XH, Li ZR, Lee KM, Leung KS (2009) A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 44(2):345–356PubMedCrossRef Zhang G, Qin L, Sheng H, Wang XL, Wang YX, Yeung DK, Griffith JF, Yao XS, Xie XH, Li ZR, Lee KM, Leung KS (2009) A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 44(2):345–356PubMedCrossRef
14.
go back to reference Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Masada T, Kobayashi A, Asada A, Takaoka K (2008) Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci 13:463–468PubMedCrossRef Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Masada T, Kobayashi A, Asada A, Takaoka K (2008) Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci 13:463–468PubMedCrossRef
15.
go back to reference Mody N, Parhami F, Sarafian TA et al (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509–519PubMedCrossRef Mody N, Parhami F, Sarafian TA et al (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509–519PubMedCrossRef
16.
go back to reference Jones JP Jr (1994) Concepts of etiology and early pathogenesis of osteonecrosis. Instr Course Lect 43:499–512PubMed Jones JP Jr (1994) Concepts of etiology and early pathogenesis of osteonecrosis. Instr Course Lect 43:499–512PubMed
17.
go back to reference Kabata T, Kubo T, Matsumoto T et al (2000) Apoptotic cell death in steroid induced osteonecrosis: an experimental study in rabbits. J Rheumatol 27:2166–2171PubMed Kabata T, Kubo T, Matsumoto T et al (2000) Apoptotic cell death in steroid induced osteonecrosis: an experimental study in rabbits. J Rheumatol 27:2166–2171PubMed
18.
go back to reference Abeles M, Urman JD, Rothfield NF (1978) Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med 138:750–754PubMedCrossRef Abeles M, Urman JD, Rothfield NF (1978) Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med 138:750–754PubMedCrossRef
19.
go back to reference Zalavras C, Dailiana Z, Elisaf M et al (2000) Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest 30:215–221PubMedCrossRef Zalavras C, Dailiana Z, Elisaf M et al (2000) Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest 30:215–221PubMedCrossRef
20.
go back to reference Irisa T, Yamamoto T, Miyanishi K, Yamashita A, Iwamoto Y, Sugioka Y et al (2001) Osteonecrosis induced by a single administration of low-dose lipopolysaccharide in rabbits. Bone 28:641–649PubMedCrossRef Irisa T, Yamamoto T, Miyanishi K, Yamashita A, Iwamoto Y, Sugioka Y et al (2001) Osteonecrosis induced by a single administration of low-dose lipopolysaccharide in rabbits. Bone 28:641–649PubMedCrossRef
21.
go back to reference Dobmeyer TS, Findhammer S, Dobmeyer JM, Klein SA, Raffel B, Hoelzer D, Helm EB, Kabelitz D, Rossol R (1997) Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 22:775–785PubMedCrossRef Dobmeyer TS, Findhammer S, Dobmeyer JM, Klein SA, Raffel B, Hoelzer D, Helm EB, Kabelitz D, Rossol R (1997) Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 22:775–785PubMedCrossRef
22.
go back to reference Kurata T, Oguri T, Isobe T, Ishioka S, Yamakido M (1999) Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res 90:1238–1243PubMedCrossRef Kurata T, Oguri T, Isobe T, Ishioka S, Yamakido M (1999) Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res 90:1238–1243PubMedCrossRef
23.
go back to reference Li X, Cobb CE, Hill KE, Burk RF, May JM (2001) Mitochondrial uptake and recycling of ascorbic acid. Arch Biochem Biophys 387:143–153PubMedCrossRef Li X, Cobb CE, Hill KE, Burk RF, May JM (2001) Mitochondrial uptake and recycling of ascorbic acid. Arch Biochem Biophys 387:143–153PubMedCrossRef
24.
go back to reference Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 44: 456–460 Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 44: 456–460
Metadata
Title
Lipoic acid prevents steroid-induced osteonecrosis in rabbits
Authors
Bang-Bao Lu
Kang-Hua Li
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1846-6

Other articles of this Issue 6/2012

Rheumatology International 6/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.